| Literature DB >> 28661835 |
Abstract
In some respects, the 1983 Orphan Drug Act is a success story. But high prices and allegations that some drug companies have twisted the law to their advantage have made it controversial. Here are some of the main points in the debate.Entities:
Mesh：
Year: 2017 PMID： 28661835
Source DB: PubMed Journal: Manag Care ISSN： 1062-3388